Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.

類似資料

• Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.
  著者:: Spronk, P E, 等
  出版事項: (1994)
• Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?
  著者:: Spronk, P E, 等
  出版事項: (1992)
• Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.
  著者:: ter Borg, E J, 等
  出版事項: (1990)
• The soluble CD40 ligand sCD154 in systemic lupus erythematosus
  著者:: Kato, Kazunori, 等
  出版事項: (1999)
• Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?
  著者:: Spronk, P E, 等
  出版事項: (1992)